Sigurður Ingvarsson

Cited by

	All	Since 2019
Citations	4982	442
h-index	36	11
i10-index	73	14

280

140

210

198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202425 64 67 76 81 78 71 74 62 136 160 214 199 213 242 225 270 210 208 182 200 152 179 160 138 180 165 146 98 93 97 88 107 105 63 61 18

Public access

View all

1 article

0 articles

available

not available

Based on funding mandates

Co-authors

Barkardottir R BLaboratory of Cell Biology, Department of Pathology, Landspitali University Hospital, ReykjavikVerified email at landspitali.is
Jón Gunnlaugur JónassonProfessor of Pathology, University of IcelandVerified email at landspitali.is
Bjarni Agnar AgnarssonProfessor of PathologyVerified email at landspitali.is
Jon Thor BergthorssonPL Biomedical Center, University of IcelandVerified email at hi.is
Adalgeir ArasonLaboratory of Cell Biology, Department of Pathology, Landspitali - The National University HospitalVerified email at landspitali.is
Gisli RagnarssonProject leader deCODE GeneticsVerified email at decode.is
Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se
Óskar JóhannssonVerified email at landspitali.is
Xiyin WangMayo Clinic Graduate School of Biomedical SciencesVerified email at mayo.edu
Valgerdur AndrésdóttirResearch Scientist, Institute for Experimental Pathology, Keldur, University of IcelandVerified email at hi.is
Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeVerified email at medschl.cam.ac.uk
Giandomenico RussoScientific Director IDI-IRCCS, Roma, ItalyVerified email at idi.it
Oreste SegattoRegina Elena National Cancer InstituteVerified email at ifo.gov.it
Ogmundsdottir HMProfessor of Cell Biology, Faculty of Medicine, University of IcelandVerified email at hi.is
Laufey TryggvadottirProfessor, Faculty of Medicine, University of IcelandVerified email at krabb.is
Prof. Tyson V. SharpBarts Cancer Institute, Queen Mary University of LondonVerified email at qmul.ac.uk
Vilmundur GudnasonProfessor of Cardiovascular Genetics, University of Iceland, Director Icelandic Heart AssociationVerified email at hjarta.is
Uta FranckeProfessor of Genetics, Stanford UniversityVerified email at stanford.edu
Ólafur S. AndréssonProfessor of Genetics University of IcelandVerified email at hi.is
Stefan JonssonInstitute for Experimental Pathology, University of IcelandVerified email at hi.is

Sigurður Ingvarsson

Professor, University of Iceland

Verified email at hi.is - Homepage

Cancer biology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations M Tirkkonen, O Johannsson, BA Agnarsson, H Olsson, S Ingvarsson, ... Proceedings of the American Association for Cancer Research 38, 510, 1997	483	1997
Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. G Kovacs, R Erlandsson, F Boldog, S Ingvarsson, R Müller-Brechlin, ... Proceedings of the National Academy of Sciences 85 (5), 1571-1575, 1988	413	1988
High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients G Johannesdottir, J Gudmundsson, JT Bergthorsson, A Arason, ... Cancer research 56 (16), 3663-3665, 1996	314	1996
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12–q13 J Gudmundsson, G Johannesdottir, JT Bergthorsson, A Arason, ... Cancer research 55 (21), 4830-4832, 1995	218	1995
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival G Ragnarsson, G Eiriksdottir, JT Johannsdottir, JG Jonasson, V Egilsson, ... British journal of cancer 79 (9-10), 1468-1474, 1999	196	1999
Molecular genetics of breast cancer progression S Ingvarsson Seminars in cancer biology 9 (4), 277-288, 1999	190	1999
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis G Eiriksdottir, G Johannesdottir, S Ingvarsson, IB Björnsdottir, ... European Journal of Cancer 34 (13), 2076-2081, 1998	141	1998
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin S Anastasi, G Sala, C Huiping, E Caprini, G Russo, S Iacovelli, F Lucini, ... Oncogene 24 (28), 4540-4548, 2005	139	2005
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer C Huiping, JR Sigurgeirsdottir, JG Jonasson, G Eiriksdottir, ... British journal of cancer 81 (7), 1103-1110, 1999	133	1999
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer C Huiping, S Kristjansdottir, JT Bergthorsson, JG Jonasson, J Magnusson, ... European Journal of Cancer 38 (5), 728-735, 2002	125	2002
Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. J Gudmundsson, RB Barkardottir, G Eiriksdottir, T Baldursson, A Arason, ... British journal of cancer 72 (3), 696-701, 1995	116	1995
Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance KS Asgeirsson, JG Jónasson, L Tryggvadóttir, K Olafsdottir, ... European Journal of Cancer 36 (9), 1098-1106, 2000	112	2000
Structure and expression of B-myc, a new member of the myc gene family S Ingvarsson, C Asker, H Axelson, G Klein, J Sümegi Molecular and cellular biology, 1988	112	1988
Alterations of E-cadherin and β-catenin in gastric cancer C Huiping, S Kristjansdottir, JG Jonasson, J Magnusson, V Egilsson, ... BMC cancer 1, 1-7, 2001	109	2001
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity DE Foxler, KS Bridge, V James, TM Webb, M Mee, SCK Wong, Y Feng, ... Nature Cell Biology 14 (2), 201-208, 2012	103	2012
Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes MG Mattei, M Rivière, A Krust, S Ingvarsson, B Vennström, MQ Islam, ... Genomics 10 (4), 1061-1069, 1991	102	1991
Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas S Ingvarsson, BA Agnarsson, BI Sigbjornsdottir, J Kononen, ... Cancer research 59 (11), 2682-2689, 1999	85	1999
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers S Ingvarsson, BI Sigbjörnsdottir, SH Hafsteinsdottir, V Egilsson, ... European Journal of Cancer 37, S261, 2001	84	2001
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. J Gudmundsson, G Johannesdottir, A Arason, JT Bergthorsson, ... American journal of human genetics 58 (4), 749-756, 1996	79	1996
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma LF Hu, G Eiriksdottir, T Lebedeva, I Kholodniouk, A Alimov, F Chen, Y Luo, ... Genes, Chromosomes and Cancer 17 (2), 118-126, 1996	66	1996

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors